Issue 12/2018
Content (33 Articles)
Prognostic and therapeutic stratification in CLL: focus on 17p deletion and p53 mutation
Valeria Buccheri, Wolney Gois Barreto, Laura Maria Fogliatto, Marcelo Capra, Mariana Marchiani, Vanderson Rocha
The optimal timing of radiotherapy in the combined modality therapy for limited-stage extranodal NK/T cell lymphoma (ENKTL): a systematic review and meta-analysis
Shaoxuan Hu, Daobin Zhou, Wei Zhang
Establishment of a flow cytometry assay for detecting paroxysmal nocturnal hemoglobinuria-type cells specific to patients with bone marrow failure
Kohei Hosokawa, Chiharu Sugimori, Ken Ishiyama, Hiroyuki Takamatsu, Hideyoshi Noji, Tsutomu Shichishima, Naoshi Obara, Shigeru Chiba, Haruhiko Ninomiya, Yukari Shirasugi, Yoshihiko Nakamura, Kiyoshi Ando, Yasutaka Ueda, Yuji Yonemura, Tatsuya Kawaguchi, Jun-ichi Nishimura, Yuzuru Kanakura, Shinji Nakao
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
Dorota Link-Lenczowska, Niels Pallisgaard, Sabrina Cordua, Magdalena Zawada, Sylwia Czekalska, Dorota Krochmalczyk, Zuzanna Kanduła, Tomasz Sacha
Response to hypomethylating agents improves long-term outcomes for lower-risk patients with myelodysplastic syndrome in case-matched cohorts
Dong Won Baek, Yoo Jin Lee, Hyunjeong Kim, Seo Yeon Ahn, Jae Sook Ahn, Ho Jin Shin, Won Sik Lee, Sang Min Lee, Ik Chan Song, Ho Sup Lee, Sung Woo Park, Yunsuk Choi, Yoon Young Cho, Sung Hwa Bae, Hyeoung Joon Kim, Sang Kyun Sohn, Joon Ho Moon
A monocentric retrospective study of 138 therapy-related myeloid neoplasms
Helena Claerhout, Els Lierman, Lucienne Michaux, Gregor Verhoef, Nancy Boeckx
Long-term outcome of high risk patients with myelodysplastic syndromes or secondary acute myeloid leukemia receiving intensive chemotherapy
Esther Schuler, Natalie Zadrozny, Sabine Blum, Thomas Schroeder, Corinna Strupp, Barbara Hildebrandt, Andrea Kündgen, Norbert Gattermann, Carlo Aul, Mustafa Kondakci, Guido Kobbe, Rainer Haas, Ulrich Germing
Be careful of the masquerades: differentiating secondary myelodysplasia from myelodysplastic syndromes in clinical practice
Rory M. Shallis, Mina L. Xu, Nikolai A. Podoltsev, Susanna A. Curtis, Bryden T. Considine, Suchin R. Khanna, Alexa J. Siddon, Amer M. Zeidan
Clinical value of abnormal findings on brain magnetic resonance imaging in patients with intravascular large B-cell lymphoma
Yoshiaki Abe, Kentaro Narita, Hiroki Kobayashi, Akihiro Kitadate, Masami Takeuchi, Yoichi Kikuchi, Toshihiro Ouchi, Kengo Takeuchi, Kosei Matsue
Novel synthetic 4-chlorobenzoyl berbamine inhibits c-Myc expression and induces apoptosis of diffuse large B cell lymphoma cells
Lei Zhang, Jiefeng Tong, Xin He, Yun Liang, Lei Zhu, Rongzhen Xu, Xiaoying Zhao
The cell-of-origin classification of diffuse large B cell lymphoma in a Korean population by the Lymph2Cx assay and its correlation with immunohistochemical algorithms
Hee Sang Hwang, Dok Hyun Yoon, Jung Yong Hong, Chan-Sik Park, Yoon Se Lee, Young Hyeh Ko, Seok Jin Kim, Won Seog Kim, Cheolwon Suh, Jooryung Huh
Characteristics of pulmonary complications in non-Hodgkin’s lymphoma patients treated with rituximab-containing chemotherapy and impact on survival
Kimberly Keefer, Regis Bender, Jason Liao, Jeffrey Sivik, Andry Van de Louw
Persistent peripheral blood EBV-DNA positive with high expression of PD-L1 and upregulation of CD4 + CD25 + T cell ratio in early stage NK/T cell lymphoma patients may predict worse outcome
Peng-fei Li, Yi-ze Mao, Bing Bai, Yan Gao, Yu-jing Zhang, Zhi-ming Li, Wen-qi Jiang, Hui-qiang Huang
Impact of front line relative dose intensity for methotrexate and comorbidities in immunocompetent elderly patients with primary central nervous system lymphoma
Jonathan Farhi, Kamel Laribi, Corentin Orvain, Jean-François Hamel, Mélanie Mercier, Aurélien Sutra Del Galy, Aline Clavert, Marie-Christine Rousselet, Aline Tanguy-Schmidt, Mathilde Hunault-Berger, Marie-Pierre Moles-Moreau
Transient adrenal insufficiency in diffuse large B cell lymphoma patients after chemotherapy with short-course, high-dose corticosteroids
Weerapat Owattanapanich, Sirinart Sirinvaravong, Kittima Suphadirekkul, Taweesak Wannachalee
Radiation therapy in indolent primary cutaneous B cell lymphoma: a single institute experience
Francesca De Felice, Lavinia Grapulin, Alessandra Pieroni, Francesca Salerno, Gianna Maria D’Elia, Alessandro Pulsoni, Daniela Musio, Vincenzo Tombolini
Posttransplant monomorphic Burkitt’s lymphoma: clinical characteristics and outcome of a multicenter series
S. Bobillo, P. Abrisqueta, B. Sánchez-González, E. Giné, S. Romero, M. Alcoceba, E. González-Barca, S. González de Villambrosía, J. M. Sancho, P. Gómez, L. Bento, J. Montoro, S. Montes, A. López, F. Bosch
Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry
Rafat Abonour, Lynne Wagner, Brian G.M. Durie, Sundar Jagannath, Mohit Narang, Howard R. Terebelo, Cristina J. Gasparetto, Kathleen Toomey, James W. Hardin, Amani Kitali, Craig J. Gibson, Shankar Srinivasan, Arlene S. Swern, Robert M. Rifkin
Survival of non-transplant patients with multiple myeloma in routine care differs from that in clinical trials—data from the prospective German Tumour Registry Lymphatic Neoplasms
Wolfgang Knauf, Ali Aldaoud, Ulrich Hutzschenreuter, Martine Klausmann, Stephanie Dille, Natalie Wetzel, Martina Jänicke, Norbert Marschner
Nucleic acid based risk assessment and staging for clinical practice in multiple myeloma
Ritu Gupta, Gurvinder Kaur, Lalit Kumar, Lata Rani, Nitin Mathur, Atul Sharma, Meetu Dahiya, Varun Shekhar, Sadaf Khan, Anjali Mookerjee, Om Dutt Sharma
Impact of elotuzumab treatment on pain and health-related quality of life in patients with relapsed or refractory multiple myeloma: results from the ELOQUENT-2 study
David Cella, Jan McKendrick, Amber Kudlac, Antonio Palumbo, Abderrahim Oukessou, Ravi Vij, Teresa Zyczynski, Catherine Davis
Clinical presentation and prognosis of light-chain amyloidosis patients with unmeasurable free light-chain levels
Yu Qiu, Cong-li Zhang, Kai-ni Shen, Wei Su, Jun Feng, Lu Zhang, Xin-xin Cao, Jian Li
Prospective evaluation of metabolic syndrome and its features in a single-center series of hematopoietic stem cell transplantation recipients
Claudio Annaloro, Lorena Airaghi, Diana Giannarelli, Gabriella Mometto, Alessandra Orsatti, Giorgia Saporiti, Federica Irene Grifoni, Marina Baldini, Elena Tagliaferri, Daniele Vincenti, Diletta Maira, Francesco Onida, Agostino Cortelezzi
Sequential treatment combining cladribine-based re-induction, myeloablative allogeneic HSCT, and prophylactic donor lymphocyte infusion: a promising treatment for refractory acute myeloid leukemia
Haowen Xiao, Li Li, Yan Pang, Yuanbin Wu, Zujun Jiang, Zenghui Liu, Jiulong Wu, Yang Xiao, Fen Huang, Qifa Liu, Hang Zhang, Yi Luo, He Huang
Second allogeneic hematopoietic cell transplantation enables long-term disease-free survival in relapsed acute leukemia
Corina Schneidawind, Volker Hagmaier, Christoph Faul, Lothar Kanz, Wolfgang Bethge, Dominik Schneidawind
Course of colonization by multidrug-resistant organisms after allogeneic hematopoietic cell transplantation
D. Heidenreich, S. Kreil, M. Jawhar, N. Müller, F. Nolte, K-P. Becker, T. Miethke, W.-K. Hofmann, Stefan A. Klein
The pharmacokinetics and pharmacodynamics of busulfan when combined with melphalan as conditioning in adult autologous stem cell transplant recipients
Abbey Willcox, Eric Wong, Christa Nath, Brett Janson, Simon J. Harrison, Rosemary Hoyt, Ashish Bajel, Peter Shaw, David Ritchie, Andrew Grigg
Management of Dabigatran-associated bleeding in two elderly patients with acute renal failure
Christian Pfrepper, Alexander Peschka, Lorenz Weidhase, Thorsten Kaiser, Sirak Petros, Michael Metze
Clinical characteristics and treatment outcome of an 86-year-old patient with acute myeloid leukaemia with acute promyelocytic-like morphology and uncommon RARA fusion variant
Roberto Castelli, Valentina Rossi, Matteo Giovanni della Porta, Riccardo Schiavon, Marco Barchiesi, Laura Cicconi, Francesco Lo Coco
Hairy cell leukemia presenting with progressive pericarditis and pleuritis
Atsushi Iwashige, Makoto Hirosawa, Junichi Tsukada
Correction to: Multicenter phase 1/2 study of forodesine in patients with relapsed peripheral T cell lymphoma
Dai Maruyama, Kunihiro Tsukasaki, Toshiki Uchida, Yoshinobu Maeda, Hirohiko Shibayama, Hirokazu Nagai, Mitsutoshi Kurosawa, Yoko Suehiro, Kiyohiko Hatake, Kiyoshi Ando, Isao Yoshida, Michihiro Hidaka, Tohru Murayama, Yoko Okitsu, Norifumi Tsukamoto, Masafumi Taniwaki, Junji Suzumiya, Kazuo Tamura, Takahiro Yamauchi, Ryuzo Ueda, Kensei Tobinai
Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia
Andreas Tiede, Andrew Worster